| Entry |
|
|---|
| Name |
Enfuvirtide (USAN/INN);
Fuzeon (TN)
|
|---|
| Product |
|
|---|
| Formula |
C204H301N51O64
|
|---|
| Exact mass |
4489.1866
|
|---|
| Mol weight |
4491.876
|
|---|
| Sequence |
Ac-Tyr Thr Ser Leu Ile His Ser Leu Ile Glu Glu Ser Gln Asn Gln Gln
Glu Lys Asn Glu Gln Glu Leu Leu Glu Leu Asp Lys Trp Ala Ser Leu
Trp Asn Trp Phe-NH2 |
|---|
| Type |
Peptide |
|---|
| Activity |
Antiviral [blockade of gp-41 mediated membrane fusion] [DS: H00406]
|
|---|
| Remark |
|
|---|
| Comment |
fusion inhibitor
|
|---|
| Target |
HIV glycoprotein 41 (gp41) |
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AX Other antivirals
J05AX07 Enfuvirtide
D02499 Enfuvirtide (USAN/INN)
USP drug classification [BR:br08302]
Antivirals
Anti-HIV Agents, Other
Enfuvirtide
D02499 Enfuvirtide (USAN/INN)
Antiinfectives [BR:br08307]
Antivirals
Anti-HIV agent
Entry / fusion inhibitor
HIV glycoprotein 41 (gp41) inhibitor
Enfuvirtide [ATC:J05AX07]
D02499 Enfuvirtide (USAN/INN)
 |
|---|
| Other DBs |
CAS: 159519-65-0 PubChem: DrugBank: NIKKAJI: |
|---|
